European equities traded in the US as American depositary receipts were higher late Thursday morning, rising 0.60% to 1,514.46 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by semiconductor company Sequans Communications (SQNS) and biopharmaceutical company Grifols (GRFS), which advanced 13% and 3.3%, respectively. They were followed by medical device maker EDAP TMS (EDAP) and electronics conglomerate Philips (PHG), which were up 2.6% and 1.8%, respectively.
The decliners from continental Europe were led by financial services company Banco Santander (SAN) and 3D printer company Materialise (MTLS), which fell 2.8% and 1.8%, respectively. They were followed by financial services company Banco Bilbao Vizcaya Argentaria (BBVA) and software firm SAP (SAP), which were down 1.6% and 1.4%, respectively.
From the UK and Ireland, the gainers were led by mining company BHP Group (BHP) and tobacco company British American Tobacco (BTI), which rose 4.3% and 2%, respectively. They were followed by medical device maker Smith & Nephew (SNN) and pharmaceutical company GSK (GSK), which dropped 1.9% and 1.8%, respectively.
The decliners from the UK and Ireland were led by biopharmaceutical company Mereo BioPharma Group (MREO) and software company Endava (DAVA), which dropped 34% and 3%, respectively. They were followed by biopharmaceutical companies Bicycle Therapeutics (BCYC) and Biodexa Pharmaceuticals (BDRX), which lost 1.5% and 1.1%, respectively.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.